Cholesterol-lowering drugs also may protect stem cell transplant patients from graft-versus-host disease

Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the US. Now a new study indicates that statins may protect stem cell transplant patients from one of the most serious complications of the life-saving cancer therapy: graft-versus-host disease, or GVHD.

Read the whole article on Science Daily

More from Science Daily